Expanding LogP: Present possibilities-Reference-Cited by-同舟云学术

Expanding LogP: Present possibilities

Published:2018-03 Issue: Volume:58 Page:20-32
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Vraka Chrysoula,Mijailovic Sanja,Fröhlich Vanessa,Zeilinger Markus,Klebermass Eva-Maria,Wadsak Wolfgang^ORCID,Wagner Karl-Heinz^ORCID,Hacker Marcus,Mitterhauser Markus

Funder

Austrian Science Fund

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference41 articles.

1. Blood-brain barrier drug targeting: the future of brain drug development;Pardridge;Mol Interv,2003

2. The role of blood-brain barrier studies in the pharmaceutical industry;Reichel;Curr Drug Metab,2006

3. Interactive association of drugs binding to human serum albumin;Yang;Int J Mol Sci,2014

4. Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning;Hollósy;J Med Chem,2006

5. Predicting plasma protein binding of drugs: a new approach;Kratochwil;Biochem Pharmacol,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Naphtho[1′,2′4,5]imidazo[2,1‐b]thiazoles via CuCl‐Catalyzed Cross‐Coupling of Ethynylimidazothiazoles With N‐tosyl Hydrazones and Their Antitubercular Activity;Asian Journal of Organic Chemistry;2024-08-05

2. Chemical profiling of essential oils: Investigations into modulating milk production in dairy cows using in silico methods;Sciences of Phytochemistry;2024-04-16

3. Metal‐Free Regioselective Oxidative C−H Trifluoromethylation of Imidazothiazoles and Their Antitubercular Activity;ChemistrySelect;2024-03-21

4. Synthesis and biological evaluation of novel 18F-labeled 2,4-diaminopyrimidine derivatives for detection of ghrelin receptor in the brain;Bioorganic & Medicinal Chemistry Letters;2024-02

5. N‐Substituted piperazine‐coupled imidazo[2,1‐b]thiazoles as inhibitors of Mycobacterium tuberculosis: Synthesis, evaluation, and docking studies;Drug Development Research;2024-01-30